Medco Decision To Avoid “At-Risk” Medicare Rx Plans Is “Premature,” CMS Says

PBMs should wait to see Part D implementing regs before deciding whether to offer a stand-alone drug plan, CMS’ Trysla says. PCMA and CMS Administrator McClellan discuss Medco’s position on the drug benefit.